Brief: Factor Therapeutics Enters Commercial Agreement For Veterinary Medical Technology Pipeline
24/07/2020 01:08
July 24 (Reuters) - Factor Therapeutics Ltd FTT.AX :
* FACTOR THERAPEUTICS LTD- ENTERS INTO COMMERCIAL AGREEMENT
FOR
VETERINARY MEDICAL TECHNOLOGY PIPELINE
Source text for Eikon: ID:nASX7QpK7M
Further company coverage: FTT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InVert Graphite
See all newsBrief: Invert Graphite Says Rapidgraphite Acquisition Now Unconditional
Australia's InVert Graphite rises on acquiring graphite processing technology provider
Brief: Invert Graphite Seeks Trading Halt
Brief: Invert Graphite Says CEO Andrew Lawson Transitions To Managing Director
Brief: Invert Graphite Says David Brookes Has Resigned As Non-Executive Chair